291 related articles for article (PubMed ID: 23321955)
21. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
[TBL] [Abstract][Full Text] [Related]
22. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
Harpaz R; van Hoek AJ
J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
[TBL] [Abstract][Full Text] [Related]
23. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
[TBL] [Abstract][Full Text] [Related]
24. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
[TBL] [Abstract][Full Text] [Related]
25. The case against universal varicella vaccination.
Goldman GS
Int J Toxicol; 2006; 25(5):313-7. PubMed ID: 16940003
[TBL] [Abstract][Full Text] [Related]
26. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
Gao Z; Gidding HF; Wood JG; MacIntyre CR
Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
[TBL] [Abstract][Full Text] [Related]
27. Vaccination to prevent varicella and shingles.
Breuer J
J Clin Pathol; 2001 Oct; 54(10):743-7. PubMed ID: 11577118
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.
Hoshi SL; Seposo X; Shono A; Okubo I; Kondo M
Vaccine; 2019 Jun; 37(27):3588-3597. PubMed ID: 31153691
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
[TBL] [Abstract][Full Text] [Related]
30. Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
[TBL] [Abstract][Full Text] [Related]
31. Varicella zoster vaccines.
Creed R; Satyaprakash A; Ravanfar P
Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
[TBL] [Abstract][Full Text] [Related]
32. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
Kelly HA; Grant KA; Gidding H; Carville KS
Euro Surveill; 2014 Oct; 19(41):. PubMed ID: 25345520
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of varicella vaccination programs: an update of the literature.
Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
[TBL] [Abstract][Full Text] [Related]
34. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
[TBL] [Abstract][Full Text] [Related]
35. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
[TBL] [Abstract][Full Text] [Related]
36. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.
Schuette MC; Hethcote HW
Bull Math Biol; 1999 Nov; 61(6):1031-64. PubMed ID: 17879870
[TBL] [Abstract][Full Text] [Related]
37. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of the cost effectiveness of herpes zoster vaccination.
Szucs TD; Pfeil AM
Pharmacoeconomics; 2013 Feb; 31(2):125-36. PubMed ID: 23335045
[TBL] [Abstract][Full Text] [Related]
39. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
40. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]